Novavax (NVAX): a super-risky investment value proposition

8:48 am ET, 08 Aug 2018

Novavax, Inc. (NVAX) is a little biotech that many investors have given up on.  Its shares are trading at 1.23, up 2%. What should investors know about Novovax? What's NVAX stock price forecast?

While Novavax has some positives, it is not a good candidate for new money.  Novavax's two marquee programs, RSV F for maternal vaccination and NanoFlu are not doing particularly well, as they are getting delayed. 

RSV F for maternal vaccination is now in Phase 3, but many investors are wondering if it's a viable drug.  Even if Novavax successfully meets the development challenges, it may face strong competition from other biotech companies.  

One possibility for Novovax is to be bought out, in which case the stock may be underpriced.  

Let's look at the sentiment analysis for Novovax.  Our technical analysis shows that: 

  • The stock short-term sentiment (next 30 days) is negative;
  • The mid-term sentiment (3-6 months) is negative;
  • The long-term sentiment (9-12 months) is negative. 

Over the last month, Novavax, Inc. (NVAX) returned -14.6%.

Novavax, Inc. (NVAX) short share of float is 13.28%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock.

Novavax, Inc. (NVAX) average analyst price target ($3.93) is 235.9% above its current price ($1.17).

For the latest price and information on Novavax, Inc., please visit Finstead and search for "NVAX price" or "NVAX news".

Novavax, Inc. (NVAX) Stock Guide

Updated at: 12:37 am ET, 22 Sep 2020

Before we start: if you're looking for NVAX stock price, you can quickly find it out by visiting Finny and typing "NVAX quote". If you're looking for a quick scoop on NVAX stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "NVAX". You'll get all this info in one place. Or you can just type "NVAX news" to get the latest stock news.

Looking to buy or sell Novavax, Inc. (NVAX)? Interested in getting the full scoop on NVAX, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this NVAX stock guide, we'll address key questions about NVAX, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Earnings and Dividends: earnings, earnings date, dividend rate and dividend yield;
Analyst Predictions: stock forecast and analyst ratings;
Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. What are NVAX earnings?
2. When is NVAX earnings date?
3. What is NVAX stock forecast (i.e., prediction)?
4. NVAX buy or sell? What is NVAX Finny Score?
5. What are the reasons to buy NVAX? Why should I buy NVAX stock?
6. What are the reasons to sell NVAX? Why should I sell NVAX stock?
7. What are NVAX key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Earnings and Dividends

1. What are NVAX earnings?

NVAX trailing 12-month earnings per share (EPS) is -$2.40.

2. When is NVAX earnings date?

NVAX earnings date is August 10, 2020.

Analyst Predictions

3. What is NVAX stock forecast (i.e., prediction)?

Based on NVAX analyst price targets, NVAX stock forecast is $227.60 (for a year from now). That means the average analyst price target for NVAX stock is $227.60. The prediction is based on 7 analyst estimates.

The low price target for NVAX is $105.00, while the high price target is $290.00.

NVAX analyst rating is Buy.

Analysis

4. NVAX buy or sell? What is NVAX Finny Score?

#{finnyScore:75}Our quantitative analysis shows 6 reasons to buy and 2 reasons to sell NVAX, resulting in Finny Score of 75.

5. What are the reasons to buy NVAX? Why should I buy NVAX stock?

Here are the reasons to buy NVAX stock:

6. What are the reasons to sell NVAX? Why should I sell NVAX stock?

Let's look at the reasons to sell NVAX stock (i.e., the bear case):

Key Stats

7. What are NVAX key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for NVAX:

Metrics NVAX
Price $108.42
Average Price Target / Upside $227.60 / 109.92%
Average Analyst Rating Buy
Forward Dividend Yield 0.00%
Industry Biotechnology
Sector Healthcare
Number of Employees 362
Market Cap $6.44B
Forward P/E Ratio 4.83
Price/Book Ratio 128.17
Revenue (TTM) $50.24M
YoY Quarterly Revenue Growth 958.60%
Profit Margin -185.63%

If you liked this analysis, check out Stock Guides for other stocks.

Follow Us